Gene · 6041
Papers3,466
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,466
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparison of transcriptional responses between pathogenic and nonpathogenic hantavirus infections in Syrian hamsters using NanoString. | PLoS Negl Trop Dis | 2021 | 34339406 | PubTator, text mining | PubMed |
| Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis. | Comput Biol Med | 2021 | 34332351 | PubTator, text mining | PubMed |
| NS1: A Key Protein in the "Game" Between Influenza A Virus and Host in Innate Immunity. | Front Cell Infect Microbiol | 2021 | 34327148 | PubTator, text mining | PubMed |
| Role of interferons in diabetic retinopathy. | World J Diabetes | 2021 | 34326947 | PubTator, text mining | PubMed |
| Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across. | Adv Drug Deliv Rev | 2021 | 34324884 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block. | RNA | 2021 | 34315815 | PubTator, text mining | PubMed |
| Proteomics reveals disturbances in the immune response and energy metabolism of monocytes from patients with septic shock. | Sci Rep | 2021 | 34312428 | PubTator, text mining | PubMed |
| Interferon β, an enhancer of the innate immune response against SARS-CoV-2 infection. | Microb Pathog | 2021 | 34311016 | PubTator, text mining | PubMed |
| The Regulation Network and Clinical Significance of Circular RNAs in Breast Cancer. | Front Oncol | 2021 | 34307155 | PubTator, text mining | PubMed |
| BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression. | Clin Cancer Res | 2021 | 34301753 | PubTator, text mining | PubMed |
| Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits. | Cancers (Basel) | 2021 | 34298601 | PubTator, text mining | PubMed |
| Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation*. | Angew Chem Int Ed Engl | 2021 | 34278671 | PubTator, text mining | PubMed |
| The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection. | Arch Virol | 2021 | 34278528 | PubTator, text mining | PubMed |
| Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNase. | Nat Commun | 2021 | 34272366 | PubTator, text mining | PubMed |
| OAS1/RNase L executes RIG-I ligand-dependent tumor cell apoptosis. | Sci Immunol | 2021 | 34272227 | PubTator, text mining | PubMed |
| Current Status of Chikungunya in India. | Front Microbiol | 2021 | 34262552 | PubTator, text mining | PubMed |
| ETV7 limits antiviral gene expression and control of influenza viruses. | Sci Signal | 2021 | 34257104 | PubTator, text mining | PubMed |
| RNA-Protein Interaction Analysis of SARS-CoV-2 5' and 3' Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection. | mSystems | 2021 | 34254825 | PubTator, text mining | PubMed |
| Ancient Gene Capture and Recent Gene Loss Shape the Evolution of Orthopoxvirus-Host Interaction Genes. | mBio | 2021 | 34253028 | PubTator, text mining | PubMed |
| Systems Biomedicine of Primary and Metastatic Colorectal Cancer Reveals Potential Therapeutic Targets. | Front Oncol | 2021 | 34249670 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6041/papers?page=47